ibandronic acid has been researched along with Invasiveness, Neoplasm in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehrenfeld, M; Mayr, D; Oduncu, F; Otto, S; Pautke, C; Troeltzsch, M | 1 |
| Bielawski, KP; Bosse, U; Schlotter, CM; Vogt, U | 1 |
| Allhoff, EP; Lindenmeir, T; Rau, O; Reiher, F; Ulrich, M | 1 |
| Bauss, F; De Clerck, YA; Dunstan, C; Mundy, GR; Sasaki, A; Williams, PJ; Yoneda, T | 1 |
| Boissier, S; Clezardin, P; Delmas, PD; Magnetto, S | 1 |
| Boissier, S; Clézardin, P; Colombel, M; Delaissé, JM; Delmas, P; Ebetino, FH; Ferreras, M; Magnetto, S; Peyruchaud, O | 1 |
1 review(s) available for ibandronic acid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Root resorption caused by jaw infiltration of multiple myeloma: report of a case and literature review.
Topics: Aged; Antineoplastic Agents; Bicuspid; Bone Density Conservation Agents; Diphosphonates; Follow-Up Studies; Humans; Ibandronic Acid; Male; Mandibular Neoplasms; Molar; Multiple Myeloma; Neoplasm Invasiveness; Osteolysis; Root Resorption; Stem Cell Transplantation; Tooth Mobility | 2014 |
5 other study(ies) available for ibandronic acid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cyclophosphamide; Diphosphonates; Docetaxel; Drug Synergism; Epirubicin; Female; Fluorouracil; Humans; Ibandronic Acid; Imidazoles; In Vitro Techniques; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasms, Ductal, Lobular, and Medullary; Paclitaxel; Taxoids; Zoledronic Acid | 2004 |
[Adjuvant therapy of locally advanced prostate carcinoma with ibandronate].
Topics: Biomarkers, Tumor; Bone Density Conservation Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Diphosphonates; Drug Administration Schedule; Humans; Ibandronic Acid; Infusions, Intravenous; Long-Term Care; Male; Neoplasm Invasiveness; Neoplasm Staging; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 2007 |
Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cell Survival; Diphosphonates; Female; Genetic Therapy; Heart Ventricles; Humans; Ibandronic Acid; Mice; Mice, Nude; Neoplasm Invasiveness; Osteolysis; Protein Biosynthesis; Tibia; Tissue Inhibitor of Metalloproteinase-2; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
Additive antitumor activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to bone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Adhesion; Diphosphonates; Docetaxel; Drug Synergism; Humans; Ibandronic Acid; Neoplasm Invasiveness; Paclitaxel; Taxoids; Tumor Cells, Cultured | 1999 |
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Adhesion; Cell Cycle; Cell Movement; Clodronic Acid; Collagen; Diphosphonates; Dose-Response Relationship, Drug; Drug Combinations; Flow Cytometry; Fluorometry; Humans; Ibandronic Acid; Imidazoles; Laminin; Male; Matrix Metalloproteinases; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Prostatic Neoplasms; Proteoglycans; Pyridines; Pyridinium Compounds; Tumor Cells, Cultured; Zinc; Zoledronic Acid | 2000 |